FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2580916963> ?p ?o ?g. }

• W2580916963 endingPage "721" @default.
• W2580916963 startingPage "712" @default.
• W2580916963 abstract "This study reports on the activity of thermosensitive liposomes (TSLs) incorporating different HSPC ratios in DPPC/MSPC/PEG2000-DSPE matrix (90/10/4) plus mild hyperthermia (HT) (42 °C). TSLs were loaded with a poorly membrane permeable anticancer drug, cisplatin, through the passive equilibration method. The addition of HSPC to the corresponding DPPC lipid matrix increased the transition temperature. In vitro data demonstrated >90% cisplatin leakage from nanosized DPPC 90-lyso-TSL (LTSL) within 10 min at 42 °C, while other TSLs bearing HSPC showed greater stability. The plasma kinetics of cisplatin demonstrated higher cisplatin leakage from DPPC 90-LTSL in the first 4 h (from 17.4 to 0.4 μg/mL) compared to other formulations. Indeed, increasing HSPC fraction in liposome bilayers significantly improved drug retention in blood. Though DPPC 90-LTSL plus one-step HT was expected to provide a unique drug release, the premature drug leakage as well as the likely wash-back of a great portion of drug into the blood circulation resulted in reduced survival. On the other hand, stabilized DPPC 30/HSPC 60/MSPC 10/PEG2000-DSPE 4 liposomes plus two-step HT greatly enhanced the survival of animals. In particular, the improved delivery of cisplatin through stabilized DPPC 30/HSPC 60/MSPC 10/PEG2000-DSPE 4 liposomes in two-step mild HT enhanced antitumor efficacy compared to other formulations. Thus, prolonged exposure of cancer cells to cisplatin through stabilized liposomes would be an efficient approach in improving the survival of animals." @default.
• W2580916963 created "2017-02-03" @default.
• W2580916963 creator A5004196613 @default.
• W2580916963 creator A5007094442 @default.
• W2580916963 creator A5017947632 @default.
• W2580916963 creator A5048139853 @default.
• W2580916963 creator A5057814683 @default.
• W2580916963 creator A5060364685 @default.
• W2580916963 date "2017-02-14" @default.
• W2580916963 modified "2023-10-16" @default.
• W2580916963 title "Therapeutic Efficacy of Cisplatin Thermosensitive Liposomes upon Mild Hyperthermia in C26 Tumor Bearing BALB/c Mice" @default.
• W2580916963 cites W1058426057 @default.
• W2580916963 cites W1513897103 @default.
• W2580916963 cites W1971762800 @default.
• W2580916963 cites W1974187781 @default.
• W2580916963 cites W1975785001 @default.
• W2580916963 cites W1978521258 @default.
• W2580916963 cites W1979343074 @default.
• W2580916963 cites W1982194007 @default.
• W2580916963 cites W1988206285 @default.
• W2580916963 cites W1988607076 @default.
• W2580916963 cites W1989230986 @default.
• W2580916963 cites W1992803165 @default.
• W2580916963 cites W1993096008 @default.
• W2580916963 cites W1998886157 @default.
• W2580916963 cites W1999494701 @default.
• W2580916963 cites W2001107461 @default.
• W2580916963 cites W2002516695 @default.
• W2580916963 cites W2015626183 @default.
• W2580916963 cites W2022792152 @default.
• W2580916963 cites W2032760352 @default.
• W2580916963 cites W2040150720 @default.
• W2580916963 cites W2050129480 @default.
• W2580916963 cites W2050715080 @default.
• W2580916963 cites W2061510929 @default.
• W2580916963 cites W2079189432 @default.
• W2580916963 cites W2095156612 @default.
• W2580916963 cites W2095412415 @default.
• W2580916963 cites W2097748705 @default.
• W2580916963 cites W2098084416 @default.
• W2580916963 cites W2099017558 @default.
• W2580916963 cites W2101721772 @default.
• W2580916963 cites W2102919585 @default.
• W2580916963 cites W2103013757 @default.
• W2580916963 cites W2121013851 @default.
• W2580916963 cites W2121805411 @default.
• W2580916963 cites W2121945369 @default.
• W2580916963 cites W2122917250 @default.
• W2580916963 cites W2131438308 @default.
• W2580916963 cites W2135985260 @default.
• W2580916963 cites W2167144064 @default.
• W2580916963 cites W2185469212 @default.
• W2580916963 cites W236637588 @default.
• W2580916963 cites W4294703422 @default.
• W2580916963 cites W69913325 @default.
• W2580916963 doi "https://doi.org/10.1021/acs.molpharmaceut.6b01006" @default.
• W2580916963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28135098" @default.
• W2580916963 hasPublicationYear "2017" @default.
• W2580916963 type Work @default.
• W2580916963 sameAs 2580916963 @default.
• W2580916963 citedByCount "23" @default.
• W2580916963 countsByYear W25809169632018 @default.
• W2580916963 countsByYear W25809169632019 @default.
• W2580916963 countsByYear W25809169632020 @default.
• W2580916963 countsByYear W25809169632021 @default.
• W2580916963 countsByYear W25809169632022 @default.
• W2580916963 countsByYear W25809169632023 @default.
• W2580916963 crossrefType "journal-article" @default.
• W2580916963 hasAuthorship W2580916963A5004196613 @default.
• W2580916963 hasAuthorship W2580916963A5007094442 @default.
• W2580916963 hasAuthorship W2580916963A5017947632 @default.
• W2580916963 hasAuthorship W2580916963A5048139853 @default.
• W2580916963 hasAuthorship W2580916963A5057814683 @default.
• W2580916963 hasAuthorship W2580916963A5060364685 @default.
• W2580916963 hasConcept C12554922 @default.
• W2580916963 hasConcept C126322002 @default.
• W2580916963 hasConcept C178790620 @default.
• W2580916963 hasConcept C185154212 @default.
• W2580916963 hasConcept C185592680 @default.
• W2580916963 hasConcept C2776694085 @default.
• W2580916963 hasConcept C2778239845 @default.
• W2580916963 hasConcept C2779820397 @default.
• W2580916963 hasConcept C2779949491 @default.
• W2580916963 hasConcept C2780035454 @default.
• W2580916963 hasConcept C55493867 @default.
• W2580916963 hasConcept C71924100 @default.
• W2580916963 hasConcept C86803240 @default.
• W2580916963 hasConcept C98274493 @default.
• W2580916963 hasConceptScore W2580916963C12554922 @default.
• W2580916963 hasConceptScore W2580916963C126322002 @default.
• W2580916963 hasConceptScore W2580916963C178790620 @default.
• W2580916963 hasConceptScore W2580916963C185154212 @default.
• W2580916963 hasConceptScore W2580916963C185592680 @default.
• W2580916963 hasConceptScore W2580916963C2776694085 @default.
• W2580916963 hasConceptScore W2580916963C2778239845 @default.
• W2580916963 hasConceptScore W2580916963C2779820397 @default.
• W2580916963 hasConceptScore W2580916963C2779949491 @default.
• W2580916963 hasConceptScore W2580916963C2780035454 @default.

• next